Maintenance of muscle mass is not dependent on the calcineurin-NFAT pathway

American Journal of Physiology - Cell Physiology

Volumn 282, Issue 6 51-6, 2002, Pages

  Dupont Versteegden, Esther E ^a   Knox, Micheal ^a   Gurley, Cathy M ^a   Houlé, John D ^b   Peterson, Charlotte A ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Cyclosporin; Hindlimb suspension; Soleus; Spinal cord transection

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE; HINDLIMB; MALE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; SPINAL CORD TRANSSECTION; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0036080489     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00424.2001     Document Type: Article

References (52)

1. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells
2. Apoptosis: A mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting
3. Calcineurin: From structure to function
4. High level calcineurin activity predisposes neuronal cells to apoptosis
5. Effect of intermittent weight bearing on soleus fiber force-velocity-power and force-pCa relationships
6. Cellular adaptations of skeletal muscles to cyclosporine
7. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
8. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
9. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
10. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. Genomic sequencing
13. Calcium, calcineurin, and the control of transcription
14. Intermittent acceleration as a countermeasure to soleus muscle atrophy
15. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
16. Calcineurin is required for skeletal muscle hypertrophy
17. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth
18. Early changes in muscle fiber size and gene expression in response to spinal cord transection and exercise
19. Activated satellite cells fail to restore myonuclear number in spinal cord-transected and exercised rats
20. Mechanisms leading to restoration of muscle size with exercise and transplantation after spinal cord injury
21. Structure and variation of human ribosomal DNA: Molecular analysis of cloned fragments
22. NFAT signaling in vertebrate development
23. NF-κB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia
24. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins
25. Effects of fetal spinal cord tissue transplants and cycling exercise on the soleus muscle in spinalized rats
26. Calcineurin is downstream of the inositol 1,4,5-triphosphate receptor in the apoptotic and cell growth pathways
27. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
28. NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes
29. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin
30. Calcineurin regulates slow myosin, but not fast myosin or metabolic enzymes, during fast-to-slow transformation in rabbit skeletal muscle cell culture
31. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation
32. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
33. Two experimental strategies to restore muscle mass in adult rats following spinal cord injury
34. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
35. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo
36. Remodeling muscles with calcineurin
37. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
38. Influence of 7 days of hindlimb suspension and intermittent weight support on rat muscle mechanical properties
39. Transcription factors of the NFAT family: Regulation and function
40. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
41. β-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes
42. 2+-dependent calcineurin signalling pathway
43. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth
44. 2+-activated cell death in mammalian cells
45. Skeletal muscle calcineurin: Influence of phenotype adaptation and atrophy
46. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
47. Atrophy of the soleus muscle by hindlimb unweighting
48. 2+-induced apoptosis through calcineurin dephosphorylation of BAD
49. Soleus fiber force and maximal shortening velocity after non-weight bearing with intermittent activity
50. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type
51. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway
52. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats